A soluble acidic protein of the cell nucleus which reacts with serum from patients with systemic lupus erythermatosus and Sjögren's syndrome
- PMID: 64473
- PMCID: PMC333356
- DOI: 10.1172/JCI108637
A soluble acidic protein of the cell nucleus which reacts with serum from patients with systemic lupus erythermatosus and Sjögren's syndrome
Abstract
A soluble nuclear antigen that reacts with sera obtained from patients with systemic lupus erythematosus and Sjögren's syndrome has been described. The antigen, tentatively named the Ha antigen after the prototype serum, was shown to react with specific antibodies by precipitin, complement fixation, and immunofluorescence techniques. The Ha antigen prepared from isolated nuclei of calf thymus glands, calf liver, and rat liver showed identical immunological reactivities; a wide distribution among different species and tissues is presumed. The Ha antigen was destroyed by trypsin and relatively mild heat or pH variation from neutrality, but was resistant to DNase or RNase. Many of these characteristics are similar to those of the "B" antigen to which antibodies have recently been described in Sjögren's syndrome. The nuclear origin of the Ha antigen was confirmed by the speckled nuclear immunofluorescence staining pattern given by purified antibody to Ha obtained from a specific immune precipitate. Preliminary results showed approximately 13% of patients with systemic lupus erythematosus and 30% of patients with Sjögren's syndrome had precipitating antibodies to the Ha antigen.
Similar articles
-
Antibodies to cellular antigens in Sjögren's syndrome.J Clin Invest. 1975 May;55(5):1067-73. doi: 10.1172/JCI108007. J Clin Invest. 1975. PMID: 804494 Free PMC article.
-
[The Ha(La) antibody as a serologic marker of systemic lupus erythematosus].Z Rheumatol. 1988 Mar-Apr;47(2):86-92. Z Rheumatol. 1988. PMID: 3260430 German.
-
[Antibodies against soluble nuclear antigens of the SS-A or SS-B type. Significance in systemic lupus erythematosis (author's transl)].Nouv Presse Med. 1981 Jun 13;10(26):2179-84. Nouv Presse Med. 1981. PMID: 6973748 French.
-
The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome.Curr Opin Rheumatol. 1992 Oct;4(5):644-56. Curr Opin Rheumatol. 1992. PMID: 1419498 Review.
-
Current perspectives on serological reactions in SLE patients.Clin Exp Immunol. 1981 Apr;44(1):1-10. Clin Exp Immunol. 1981. PMID: 7021022 Free PMC article. Review. No abstract available.
Cited by
-
Characterization of a distinct nuclear acidic protein antigen (MA) and clinical findings in systemic lupus erythematosus patients with MA antibodies.J Clin Invest. 1979 Sep;64(3):820-3. doi: 10.1172/JCI109529. J Clin Invest. 1979. PMID: 89119 Free PMC article.
-
Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.Clin Rheumatol. 1990 Mar;9(1 Suppl 1):123-30. doi: 10.1007/BF02205560. Clin Rheumatol. 1990. PMID: 2203591 Review.
-
Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I.Chromosoma. 1986;94(2):132-8. doi: 10.1007/BF00286991. Chromosoma. 1986. PMID: 2428564
-
Analysis of speckled fluorescent antinuclear antibody test antisera using electrofocused nuclear antigens.J Clin Invest. 1982 Aug;70(2):296-303. doi: 10.1172/jci110617. J Clin Invest. 1982. PMID: 6808026 Free PMC article.
-
Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).Ann Rheum Dis. 1978 Aug;37(4):321-7. doi: 10.1136/ard.37.4.321. Ann Rheum Dis. 1978. PMID: 308354 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources